Argus Research Downgrades AGNC Investment to Hold
Argus Research analyst Kevin Heal downgrades AGNC Investment (NASDAQ:AGNC) from Buy to Hold.
Raymond James Downgrades Antero Resources to Market Perform
Raymond James analyst John Freeman downgrades Antero Resources (NYSE:AR) from Strong Buy to Market Perform.
Raymond James Downgrades Black Stone Minerals to Outperform, Lowers Price Target to $19
Raymond James analyst John Freeman downgrades Black Stone Minerals (NYSE:BSM) from Strong Buy to Outperform and lowers the price target from $20 to $19.
RBC Capital Downgrades Vale to Sector Perform, Lowers Price Target to $15
RBC Capital analyst Tyler Broda downgrades Vale (NYSE:VALE) from Outperform to Sector Perform and lowers the price target from $16 to $15.
Stifel Downgrades Pool to Hold, Raises Price Target to $360
Stifel analyst W. Andrew Carter downgrades Pool (NASDAQ:POOL) from Buy to Hold and raises the price target from $355 to $360.
Telsey Advisory Group Downgrades RH to Market Perform, Announces $330 Price Target
Telsey Advisory Group analyst Cristina Fernandez downgrades RH (NYSE:RH) from Outperform to Market Perform and announces $330 price target.
Loop Capital Downgrades Rent-A-Center to Hold, Announces $30 Price Target
Loop Capital analyst Anthony Chukumba downgrades Rent-A-Center (NASDAQ:RCII) from Buy to Hold and announces $30 price target.
Morgan Stanley Downgrades Clarivate to Equal-Weight, Raises Price Target to $12
Morgan Stanley analyst Toni Kaplan downgrades Clarivate (NYSE:CLVT) from Overweight to Equal-Weight and raises the price target from $11 to $12.
Raymond James Downgrades Edwards Lifesciences to Market Perform
Raymond James analyst Jayson Bedford downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Market Perform.
Credit Suisse Downgrades Brookfield to Neutral, Lowers Price Target to $41
Credit Suisse analyst Andrew Kuske downgrades Brookfield (NYSE:BN) from Outperform to Neutral and lowers the price target from $42 to $41.